ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Please note that you are viewing an archived section from 2019 and some content may be unavailable. To unlock all content for 2019, please visit the archives.

Abstract: SA-PO804

Lipoatrophy and Metabolic Disturbance in Mice with Adipose-Specific Deletion of Kindlin 2

Session Information

Category: Health Maintenance, Nutrition, and Metabolism

  • 1300 Health Maintenance, Nutrition, and Metabolism

Authors

  • Gao, Huanqing, Southern University of Science and Technology, Shenzhen, Comoros
  • Xiao, Guozhi, Southern University of Science and Technology, Shenzhen, Comoros
Background

Kindlin-2 regulates the integrin-mediated cell adhesion and migration on the extracellular matrix. Our recent studies demonstrate important roles of Kindlin-2 in regulation of mesenchymal stem cell differentiation and skeletal development.

Methods

In this study we generated adipose tissue-specific conditional knock-out Kindlin-2 mice by using the Adipoq-Cre BAC transgenic mice. We used GTT to assess the glucose tolerance and ITT to assess insulin sensitivity.

Results

The results showed that deleting Kindlin-2 expression in adipocytes in mice caused a severe lipodystrophy with drastically reduced adipose tissue mass. Kindlin-2 ablation elevated the levels of blood nonesterified fatty acids (NEFA) and triglyceride, resulting in massive fatty livers in the mutant mice fed with high fat diet (HFD). Furthermore, HFD-fed mutant mice displayed type II diabetes-like phenotypes, including elevated levels of fasting blood glucose, glucose intolerance, and peripheral insulin resistance. Kindlin-2 loss dramatically reduced the expression levels of multiple key factors, including PPARg, mTOR, AKT, and b-catenin proteins, and suppressed adipocyte gene expression and differentiation. Finally, Kindlin-2 loss drastically reduced leptin production and caused a high bone mass phenotype.

Conclusion

Our study established a critical role of Kindlin-2 in control of adipogenesis and lipid metabolism as well as bone homeostasis.

Funding

  • Government Support - Non-U.S.